Clinical Trial Update: PrP-targeting siRNA Safety & Mechanism Study [Phase 1]

View source ↗

Summary

Ongoing Phase 1 safety and mechanism study of a PrP-targeting siRNA for prion disease; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prion Disease

Drugs mentioned

• PrP-targeting siRNA (PrP-targeting siRNA)

Snippet

Sponsor: Broad Institute of MIT and Harvard | Conditions: Prion Disease | Phase 1 | Status: RECRUITING